ClinicalTrials.Veeva

Menu

Trial of Chinese Prescription on Ulcerative Colitis

S

Shanghai University of Traditional Chinese Medicine

Status

Completed

Conditions

Ulcerative Colitis

Treatments

Drug: bascial prescription plus or minus herbs depend on symptoms

Study type

Interventional

Funder types

Other

Identifiers

NCT00963287
SHTCM-003

Details and patient eligibility

About

The purpose of this study is to evaluate the efficacy and safety of the Chinese prescription on Ulcerative Colitis.

Enrollment

200 patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Clinical diagnosis of ulcerative colitis
  • Male of female patients between 18-65 years old
  • Written informed consent

Exclusion criteria

  • Combine with malignant pathology on epithelial dysplasia of mucosa
  • Combined with severe heart, gallbladder, kidney, endocrine system, hemopoietic system or nervous system disease.
  • Pregnancy or breast feeding women, or unwilling to have contraception.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

200 participants in 2 patient groups, including a placebo group

bascial prescription
Experimental group
Description:
Decoction ,two times a day,one bag of decoction one time
Treatment:
Drug: bascial prescription plus or minus herbs depend on symptoms
low does of bascial decoction
Placebo Comparator group
Description:
Decoction ,two times a day, one bag decoction of one time
Treatment:
Drug: bascial prescription plus or minus herbs depend on symptoms

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems